COVAXIN HAS 50% EFFECTIVENESS AGAINST SYMPTOMATIC COVID-19, SAYS FIRST REAL-WORLD STUDY

© Provided by The Financial Express Covaxin is a Vero cell-derived, inactivated whole-virion vaccine formulated with a novel adjuvant Bharat Biotech's Covaxin is 50 per cent effective as a vaccine against symptomatic Covid-19 infection, says a study conducted on AIIMS, New Delhi hospital workers during the second wave surge in India. The study, first of its kind of the effectiveness of a...

Source: